GGrantIndex
← Leaderboards

Anthony Boutros El-Khoueiry

University Of Southern California

$6,814,457
Attributed
$13,515,729
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY201425
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,515,729 · 6

By mechanism

P30$3,918,414 · 3
U01$3,636,750 · 1
U10$3,023,086 · 1
UG1$2,937,479 · 1

Top collaborators

Most similar at University Of Southern California

Same institution · by research overlap

Others in their field

Top investigators on “Research Personnel

Research focus

Research PersonnelClinical ResearchMalignant NeoplasmsClinical TrialsDesignSafetyTrainingEnsureMemberResponseMolecularPharmaceutical PreparationsResistanceBaseTumorInvestigationInnovationTranslationsResearch InfrastructureToxic EffectSiteTherapeutic TrialsMonitorLeadership

Grant awards (25)

NCTN - Network Lead Academic Participating Site: USC$390,493
UG1 · FY2025 · CA
Clinical Protocol and Data Management$656,287
P30 · FY2024 · CA · contact PI
NCTN - Network Lead Academic Participating Site: USC$390,494
UG1 · FY2024 · CA
Clinical Protocol and Data Management$729,217
P30 · FY2023 · CA · contact PI
NCTN - Network Lead Academic Participating Site: USC$381,932
UG1 · FY2023 · CA
Clinical Protocol and Data Management$735,429
P30 · FY2022 · CA · contact PI
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$725,319
U01 · FY2022 · AA
NCTN - Network Lead Academic Participating Site: USC$430,768
UG1 · FY2022 · CA
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$725,319
U01 · FY2021 · AA
NCTN - Network Lead Academic Participating Site: USC$409,376
UG1 · FY2021 · CA
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$724,384
U01 · FY2020 · AA
NCTN - Network Lead Academic Participating Site: USC$464,856
UG1 · FY2020 · CA
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$724,197
U01 · FY2019 · AA
Clinical Protocol and Data Management: (Core 011)$528,241
P30 · FY2019 · CA · contact PI
NCTN - Network Lead Academic Participating Site: USC$469,560
UG1 · FY2019 · CA
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors$737,531
U01 · FY2018 · AA
Clinical Protocol and Data Management: (Core 011)$528,241
P30 · FY2018 · CA · contact PI
NCI NCTN- Network Lead Academic Participating Site: USC$523,827
U10 · FY2018 · CA
Clinical Protocol and Data Management: (Core 011)$2,030
P30 · FY2018 · CA · contact PI
NCI NCTN- Network Lead Academic Participating Site: USC$596,003
U10 · FY2017 · CA
Clinical Protocol and Data Management: (Core 011)$464,465
P30 · FY2017 · CA · contact PI
NCI NCTN- Network Lead Academic Participating Site: USC$627,370
U10 · FY2016 · CA
Clinical Protocol and Data Management: (Core 011)$274,504
P30 · FY2016 · CA · contact PI
NCI NCTN- Network Lead Academic Participating Site: USC$646,885
U10 · FY2015 · CA
NCI NCTN- Network Lead Academic Participating Site: USC$629,001
U10 · FY2014 · CA